Chrystel Isca
Overview
Explore the profile of Chrystel Isca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Omarini C, Catani V, Mastrolia I, Toss A, Banchelli F, Isca C, et al.
Biomark Res
. 2025 Jan;
13(1):14.
PMID: 39849610
Emerging evidence highlights the key role of microRNA (miR)-21 in cell-to-cell communication and tumorigenesis. However, limited knowledge exists on the levels and clinical meaning of miR-21 in extracellular vesicles (EVs)...
2.
Isca C, Spinella A, Toss A, de Pinto M, Ficarra G, Fabbiani L, et al.
J Pers Med
. 2022 Dec;
12(12).
PMID: 36556228
Several authors reported an increased risk of cancer in SSc patients, including breast cancer (BC). Nevertheless, the mechanisms underlying this association have not yet been clarified. SSc and BC share...
3.
Trudu L, Guaitoli G, Bertolini F, Maur M, Santini C, Papapietro V, et al.
Immunotherapy
. 2022 Apr;
PMID: 35416048
: Aims of the study were to explore outcomes and toxicities of chemotherapy-immunotherapy (CT-IT) for patients (pts) with metastatic nonsquamous non-small-cell lung cancer (mNSCLC) in a real-world population. Clinical data...
4.
Isca C, Piacentini F, Mastrolia I, Masciale V, Caggia F, Toss A, et al.
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638377
MicroRNAs (miRNA) are small noncoding RNAs that can act as both oncogene and tumor suppressors. Deregulated miRNA expression has been detected in human cancers, including breast cancer (BC). Considering their...
5.
Toss A, Spinella A, Isca C, Vacchi C, Ficarra G, Fabbiani L, et al.
J Pers Med
. 2021 Jul;
11(6).
PMID: 34203014
Systemic Sclerosis (SSc) is a chronic disease associated with a 1.5-fold increase in cancer risk, including lung cancer, hematological malignancies, and breast cancer (BC). This is a retrospective study aiming...
6.
Omarini C, Bettelli S, Manfredini S, Barbolini M, Isca C, Cortesi G, et al.
Transl Oncol
. 2020 Jun;
13(9):100794.
PMID: 32485588
Introduction: In early-stage HER2 positive breast cancer (BC) patients, tumor response to neoadjuvant chemotherapy (NACT) predict survival outcomes. Patients achieving less than pathological complete response (pCR) have a worse prognosis,...
7.
Omarini C, Piacentini F, Sperduti I, Barbolini M, Isca C, Toss A, et al.
BMC Cancer
. 2020 May;
20(1):418.
PMID: 32404154
Background: Elderly patients are underrepresented in clinical study where combined endocrine strategies were compared to endocrine therapy (ET) in hormone receptors positive, HER2 negative, metastatic breast cancer. The role of...
8.
Omarini C, Palumbo P, Pecchi A, Draisci S, Balduzzi S, Nasso C, et al.
Cancer Manag Res
. 2020 Feb;
11:9563-9569.
PMID: 32009814
Background: Fat tissue is strongly involved in BC tumorigenesis inducing insulin resistance, chronic inflammation and hormonal changes. Computed tomography (CT) imaging instead of body mass index (BMI) gives a reliable...
9.
Toss A, Venturelli M, Sperduti I, Molinaro E, Isca C, Barbieri E, et al.
Clin Breast Cancer
. 2019 Aug;
19(6):e701-e716.
PMID: 31427171
In the last decade, several clinical trials have investigated novel endocrine combinations for the first-line treatment of hormone receptor-positive metastatic breast cancer. Nevertheless, the use of combinations for the first-line...
10.
Omarini C, Bettelli S, Caprera C, Manfredini S, Barbolini M, Moscetti L, et al.
J Cancer Res Clin Oncol
. 2019 Jan;
145(4):821-828.
PMID: 30603906
Purpose: Hormone receptors (HR) status in HER2 + breast cancer (BC) is a recognized stratification factor with relevant clinical implication. According to HR expression, HER2 + BC show different clinical...